VCAN and leiomyosarcoma: Versican-derived matrikine versikine is a biomarker of tumor response to immunotherapy (37) and regulator of tumor infiltration by T-cells (38, 39) [notably, versican itself is upregulated in cervical cancer and leiomyosarcoma (40, 41)].